US coronavirus death toll approaches milestone of 500,000 The U.S. stood Sunday at the brink of a once-unthinkable tally: 500,000 people lost to the coronavirus. A year into the pandemic, the running total of lives lost was about 498,000 — roughly... AP NEWS

The U.S. stood at the brink of a once-unthinkable tally: 500,000 people lost to the coronavirus.

Breaking down the psychology of vaccine hesitancy Identifying the psychological barriers to taking vaccines is key to reaching the vaccine-hesitant. Bryan Walsh Axios

A new survey identifies some of the psychological barriers to taking vaccines — and how to overcome them.

The big picture: With COVID vaccine production and distribution ramping up, we're going to reach a moment when supply exceeds demand, which puts a premium on finding ways to persuade the persuadable on the value of vaccines.

America's vaccine rollout has been among the best in the world It hasn't been perfect. It could be a whole lot worse. Dave Lawler Axios

America’s much-maligned vaccine rollout is actually going relatively well, at least compared to other wealthy countries.

A Third of COVID Survivors Have Long-Haul Symptoms Months after illness clears, many say symptoms like fatigue, loss of smell or taste and "brain fog" persist. WebMD

(HealthDay News) -- Many patients with mild to moderate COVID-19 could become "long haulers," suffering symptoms months after they clear their non-life-threatening infection, new research shows.

Vaccine-wary France turns to citizens’ panel to boost trust in COVID-19 shots Panel advice on vaccines could counteract legacy of mistrust from past health scandals Science | AAAS

All across Europe, coronavirus vaccines are in scarce supply. But in France, they are also surprisingly unwanted: Recent polls suggest just 57% of the country intends to get vaccinated, whereas in the United Kingdom, 89% wants to get a shot for COVID-19.